Advanced Medical Solutions Group Plc · LSE:AMS
Advanced Medical Solutions — Shareholder Meeting (May 2014)
8 slides from Advanced Medical Solutions's shareholder meeting presentation, May 20, 2014
Slide 1: Annual General Meeting
Title: Annual General Meeting Date: 20th May 2014
Slide 2: Branded Direct: 2013 progress
Branded Direct: 2013 progress £22.9m (2012: £20.1m) • ActivHeal • Revenue up 32% to £5.5m • Increasing value from clinical education programme • RESORBA • German revenue up 3% to £13.8m • Dental products and haemostats performed well • Haemostats and sutures now being sold into the NHS • LiquiBand
Slide 3: Branded Distributed: 2013 progress
Branded Distributed: 2013 progress £8.8m (2012: £6.8m) • LiquiBand • US revenue up 78% to £3.0m • More distributors in hospital sector and extended product range • France and Italy performing well • Geographic expansion plans continue • First sales in South Korea • Initial sales in Russia following
Slide 4: OEM: 2013 progress
OEM: 2013 progress £23.6m (2012: £22.0m) • Silver alginate • Revenue up 15% to £12.1m • Partners continue to access new markets and gain market share • Continue to support partners with regulatory approval assistance • Foam-based finished dressings • Revenue doubled • New trilaminate dressings a key
Slide 5: Bulk Materials: 2013 progress
Bulk Materials: 2013 progress £4.2m (2012: £3.8m) • Foam rollstock • Revenue down slightly to £3.3m • Good progress with a number of new accounts • Progress undermined by below expectation ordering from an existing customer due to de-stocking • Only just starting to see follow-on orders from 2011 pi
Slide 6: Research & Development Focus
Research & Development Focus • Inclusion of antibiotics to collagen to prevent infection following surgery • LiquiBand Applicator improvements and extending range of sizes for topical adhesives • Next generation internal fixation and sealant device • New anti-microbial and atraumatic foam dressings
Slide 7: Organisation
Organisation • Reorganisation into four Business Units delivering results • Group Quality and Regulatory function strengthened • Business systems improved • Board strengthened • Peter Steinmann appointed as Non Executive Director on 1 July 2013 • Peter Allen appointed as Non Executive Director on 5
Slide 8: Summary & Outlook
Summary & Outlook • 2013 was another strong year with progress across all our Business Units • Our Board, organisation and business systems have been strengthened • Significant organic growth opportunities remain • Investment will continue into each of our brands and to support our partners • Our R&
Advanced Medical Solutions Group — Shareholder Meeting (May 2014) on 6ix